Domperidone, a novel and safe gastrokinetic anti-nauseant for the treatment of dyspepsia and vomiting
- PMID: 582708
Item in Clipboard
Domperidone, a novel and safe gastrokinetic anti-nauseant for the treatment of dyspepsia and vomiting
Arzneimittelforschung.
1978.
Abstract
The new potent anti-nauseant 5-chloro-1-(1p[3-(2,3-dihydro-2-oxo-1H-benzimidazol-1-yl)-propyl]-4-piperidinyl)-1.3-dihydro-2H-benzimidazol-2-one (domperidone), which in contrast to available anti-emetics does not provoke extrapyramidal or adrenolytic adverse effects, also enhances gastric emptying motility. Controlled clinical trials have confirmed its prokinetic effects on the stomach and its lack of side-effects, even at high doses. This anti-nauseant appears to be a safe and effective treatment for patients, both adults and children, with dyspepsia or vomiting.
Similar articles
-
Domperidone in the treatment of functional dyspepsia in patients with delayed gastric emptying.Postgrad Med J. 1979;55 Suppl 1:30-2. Postgrad Med J. 1979. PMID: 382151 Clinical Trial.
-
[Domperidon--a new gastrokinetic and anti-emetic without central-nervous side effects].Med Klin. 1980 Jun 6;75(12):453-8. Med Klin. 1980. PMID: 7393112 German. No abstract available.
-
Domperidone for the symptomatic treatment of chronic post-prandial nausea and vomiting.Postgrad Med J. 1979;55 Suppl 1:33-5. Postgrad Med J. 1979. PMID: 382152 Clinical Trial.
-
[Pharmacologic and clinical differentiation of prokinetic drugs].Leber Magen Darm. 1996 Jul;26(4):193-8. Leber Magen Darm. 1996. PMID: 8965601 Review. German.
-
Domperidone, a new dopamine antagonist.CMAJ. 1986 Sep 1;135(5):457-61. CMAJ. 1986. PMID: 3527396 Free PMC article. Review.
Cited by
-
Lack of effect of metoclopramide and domperidone on esophageal peristalsis and esophageal acid clearance in reflux esophagitis. A randomized, double-blind study.Dig Dis Sci. 1992 Apr;37(4):583-8. doi: 10.1007/BF01307583. Dig Dis Sci. 1992. PMID: 1551349 Clinical Trial.
-
On the pharmacokinetics of domperidone in animals and man III. Comparative study on the excretion and metabolism of domperidone in rats, dogs and man.Eur J Drug Metab Pharmacokinet. 1981;6(1):49-60. doi: 10.1007/BF03189515. Eur J Drug Metab Pharmacokinet. 1981. PMID: 6788556
-
Oral domperidone: double blind comparison with placebo in irritable bowel syndrome.Gut. 1983 Dec;24(12):1135-40. doi: 10.1136/gut.24.12.1135. Gut. 1983. PMID: 6357963 Free PMC article. Clinical Trial.
-
Dopamine D-2 antagonists reverse apomorphine-induced decreased water intake in the rat: prediction of antipsychotic drugs with few extrapyramidal side-effects?J Neural Transm. 1989;76(2):79-90. doi: 10.1007/BF01578748. J Neural Transm. 1989. PMID: 2565360
-
A putative multipartite model of haloperidol interaction in apomorphine-disturbed behavior of the dog.Psychopharmacology (Berl). 1978 Dec 8;59(3):255-8. doi: 10.1007/BF00426630. Psychopharmacology (Berl). 1978. PMID: 104328